Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication
Journal of Cell Death · 2018
DOI: 10.1177/1179066018785141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Death, 2018. Verfasst von Nu T Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Patients with chronic hepatitis C virus (HCV) infection risk complications of cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Previously, our proteomic examination of hepatocytes carrying a HCV-replicon revealed that deregulation of cytoskeletal dynamics may be a potential mechanism of viral-induced HCC growth. Here, we demonstrate the effect of HCV replication on the microtubule regulator stathmin (STMN1) in HCC cells. We further explore how the altered activity or synthesis of stathmin affects cellular proliferation and sensitivity to apoptosis in control HCC cells (Huh7.5) and experimental HCV-replicon harboring HCC cells (R-Huh7.5). The HCV-replicon harboring HCC cells (R-Huh 7.5) lack viral structural genes/proteins for acute infectivity and thus is the standard model for in vitro chronic infection study. Knockdown of endogenous stathmin reduced sensitivity to apoptosis in replicon cells. Meanwhile, constitutively active stathmin increased sensitivity to apoptosis in replicon cells. In addition, overexpression of constitutively active stathmin reduced cell proliferation in both control and replicon cells. These findings implicate, for the first time, a novel role for stathmin in viral replication–related apoptosis. Stathmin’s potential role in HCV replication and HCC make it a candidate for the future study of viral-induced malignancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Hematology and Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Surgery and Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Lu, N. T., Liu, N. M., Patel, D., Vu, J. Q., Liu, L., Kim, C. Y., Cho, P., Khachatoorian, R., Patel, N., Magyar, C. E., Ganapathy, E., Arumugaswami, V., Dasgupta, A., & French, S. W. (2018). Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication. Journal of Cell Death. https://doi.org/10.1177/1179066018785141
Vancouver
Lu NT, Liu NM, Patel D, Vu JQ, Liu L, Kim CY, et al. Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication. Journal of Cell Death. 2018. doi:10.1177/1179066018785141
BibTeX
@article{Lu2018,
author = {Lu, Nu T and Liu, Natalie M and Patel, Darshil and Vu, James Q and Liu, Lisa and Kim, Chae Yeon and Cho, Peter and Khachatoorian, Ronik and Patel, Nikita and Magyar, Clara E and Ganapathy, Ekambaram and Arumugaswami, Vaithilingaraja and Dasgupta, Asim and French, Samuel Wheeler},
title = {Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication},
journal = {Journal of Cell Death},
year = {2018},
doi = {10.1177/1179066018785141}
}
EUVIMED